Publicaciones en colaboración con investigadores/as de University of Milan (8)

2024

  1. Characteristics and Survival Outcomes of Patients with Metastatic RET Fusion-Positive Solid Tumors Receiving Non-RET Inhibitor Standards of Care in a Real-World Setting

    JCO Precision Oncology, Vol. 8, Núm. 1

  2. Sesgo de género en la profesión médica en España

    XLIII Jornadas de Economía de la Salud. Políticas públicas para la salud: perspectivas desde la economía y la sanidad

2023

  1. European Society of Cardiology quality indicators for the prevention and management of cancer therapy-related cardiovascular toxicity in cancer treatment

    European Heart Journal - Quality of Care and Clinical Outcomes, Vol. 9, Núm. 1, pp. 1-7

  2. Gender inequity in the medical profession: the women doctors in Spain (WOMEDS) study

    Human Resources for Health, Vol. 21, Núm. 1

2022

  1. Pan-cancer efficacy of pralsetinib in patients with RET fusion–positive solid tumors from the phase 1/2 ARROW trial

    Nature Medicine, Vol. 28, Núm. 8, pp. 1640-1645

2020

  1. Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1–2 trials

    The Lancet Oncology, Vol. 21, Núm. 2, pp. 271-282

  2. European Society for Medical Oncology (ESMO) 2018 Congress Twitter analysis: From ethics to results through the understanding of communication and interaction flows

    ESMO Open, Vol. 5, Núm. 1

  3. Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus

    Annals of Oncology, Vol. 31, Núm. 10, pp. 1320-1335